BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24044655)

  • 1. Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat.
    Zhai W; Zheng J; Yao X; Peng B; Liu M; Huang J; Wang G; Xu Y
    BMC Complement Altern Med; 2013 Sep; 13():228. PubMed ID: 24044655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial permeability transition pore opening induces the initial process of renal calcium crystallization.
    Niimi K; Yasui T; Hirose M; Hamamoto S; Itoh Y; Okada A; Kubota Y; Kojima Y; Tozawa K; Sasaki S; Hayashi Y; Kohri K
    Free Radic Biol Med; 2012 Apr; 52(7):1207-17. PubMed ID: 22285391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB1 protects against the renal injury in a rat model of kidney stone disease and calcium oxalate monohydrate crystals-induced injury in NRK-52E cells.
    Yu L; Gan X; Bai Y; An R
    Toxicol Appl Pharmacol; 2021 Feb; 413():115394. PubMed ID: 33421503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.
    Hirose Y; Yasui T; Taguchi K; Fujii Y; Niimi K; Hamamoto S; Okada A; Kubota Y; Kawai N; Itoh Y; Tozawa K; Sasaki S; Kohri K
    Urolithiasis; 2013 Aug; 41(4):279-94. PubMed ID: 23754513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel effect of the inhibitor of mitochondrial cyclophilin D activation, N-methyl-4-isoleucine cyclosporin, on renal calcium crystallization.
    Niimi K; Yasui T; Okada A; Hirose Y; Kubota Y; Umemoto Y; Kawai N; Tozawa K; Kohri K
    Int J Urol; 2014 Jul; 21(7):707-13. PubMed ID: 24661223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic Selenium Alleviated the Formation of Ethylene Glycol-Induced Calcium Oxalate Renal Calculi by Improving Osteopontin Expression and Antioxidant Capability in Dogs.
    Liu Y; Xu H; Zhong W; Shen Q; Zhuang T; Huang K
    Biol Trace Elem Res; 2015 Dec; 168(2):392-400. PubMed ID: 26018495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kidney stone matrix: Latent potential to restrain COM induced cytotoxicity and inflammatory response.
    Narula S; Tandon S; Baligar P; Singh SK; Tandon C
    Chem Biol Interact; 2017 Dec; 278():114-122. PubMed ID: 29054323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.
    Hong SH; Lee HJ; Sohn EJ; Ko HS; Shim BS; Ahn KS; Kim SH
    Pharmacol Rep; 2013; 65(4):970-9. PubMed ID: 24145091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
    Li Y; McMartin KE
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress.
    Qin B; Wang Q; Lu Y; Li C; Hu H; Zhang J; Wang Y; Zhu J; Zhu Y; Xun Y; Wang S
    Oxid Med Cell Longev; 2018; 2018():1271864. PubMed ID: 29849862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of urinary proteins in the rat strain difference in sensitivity to ethylene glycol-induced renal toxicity.
    Li Y; McLaren MC; McMartin KE
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F605-15. PubMed ID: 20534866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis.
    Meimaridou E; Lobos E; Hothersall JS
    Am J Physiol Renal Physiol; 2006 Oct; 291(4):F731-40. PubMed ID: 16670437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
    Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of experimental rat models of renal calcium oxalate stone formation.
    Oh SY; Kwon JK; Lee SY; Ha MS; Kwon YW; Moon YT
    J Endourol; 2011 Jun; 25(6):1057-61. PubMed ID: 21568694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells.
    Yasui T; Fujita K; Asai K; Kohri K
    Int J Urol; 2002 Feb; 9(2):100-8. PubMed ID: 12028300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.
    Itoh Y; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
    J Urol; 2005 Jan; 173(1):271-5. PubMed ID: 15592095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors.
    Huang HS; Chen J; Chen CF; Ma MC
    Kidney Int; 2006 Aug; 70(4):699-710. PubMed ID: 16807540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
    Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
    Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.